Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings : focus group discussions with healthcare providers in Kenya
People who inject drugs (PWID) living with Hepatitis C (HCV) in low- and middle-income countries face substantial barriers to HCV care. We sought to gain healthcare providers' perspectives on challenges and best practices for HCV care provision among PWID in Kenya. We conducted three focus group discussions (FGD) with 23 healthcare providers working with PWID living with HCV in Nairobi and Mombasa. Transcribed interviews were analysed thematically. Overarching themes regarding HCV prevention and treatment were: (1) lack of HCV-related knowledge at the provider and patient levels; (2) stigmatisation of people living with HCV and PWID; and (3) difficulties among PWID with navigating the healthcare system. Some providers suggested systematically integrating HCV care into existing PWID-specific harm reduction programs to improve HCV care provision as well as creating national HCV guidelines to guide clinicians. This study highlights the need for national HCV treatment guidelines and increased public HCV education, as well as culturally sensitive models integrating HCV care into programs PWID are already accessing. These strategies will be useful in improving access to HCV care among PWID and has the potential to decrease HCV transmission and prevalence among this vulnerable population.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Global public health - 17(2022), 12 vom: 01. Dez., Seite 3627-3637 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Seu, Rie [VerfasserIn] |
---|
Links: |
---|
Themen: |
Focus group discussion |
---|
Anmerkungen: |
Date Completed 07.02.2023 Date Revised 02.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/17441692.2022.2110919 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM34461140X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM34461140X | ||
003 | DE-627 | ||
005 | 20231226023155.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/17441692.2022.2110919 |2 doi | |
028 | 5 | 2 | |a pubmed24n1148.xml |
035 | |a (DE-627)NLM34461140X | ||
035 | |a (NLM)35941717 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Seu, Rie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings |b focus group discussions with healthcare providers in Kenya |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.02.2023 | ||
500 | |a Date Revised 02.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a People who inject drugs (PWID) living with Hepatitis C (HCV) in low- and middle-income countries face substantial barriers to HCV care. We sought to gain healthcare providers' perspectives on challenges and best practices for HCV care provision among PWID in Kenya. We conducted three focus group discussions (FGD) with 23 healthcare providers working with PWID living with HCV in Nairobi and Mombasa. Transcribed interviews were analysed thematically. Overarching themes regarding HCV prevention and treatment were: (1) lack of HCV-related knowledge at the provider and patient levels; (2) stigmatisation of people living with HCV and PWID; and (3) difficulties among PWID with navigating the healthcare system. Some providers suggested systematically integrating HCV care into existing PWID-specific harm reduction programs to improve HCV care provision as well as creating national HCV guidelines to guide clinicians. This study highlights the need for national HCV treatment guidelines and increased public HCV education, as well as culturally sensitive models integrating HCV care into programs PWID are already accessing. These strategies will be useful in improving access to HCV care among PWID and has the potential to decrease HCV transmission and prevalence among this vulnerable population | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Hepatitis C virus | |
650 | 4 | |a Kenya | |
650 | 4 | |a focus group discussion | |
650 | 4 | |a injection drug use | |
650 | 4 | |a people who inject drugs | |
700 | 1 | |a Riback, Lindsey R |e verfasserin |4 aut | |
700 | 1 | |a Nyakowa, Mercy |e verfasserin |4 aut | |
700 | 1 | |a Lizcano, John |e verfasserin |4 aut | |
700 | 1 | |a Musyoki, Helgar |e verfasserin |4 aut | |
700 | 1 | |a Ross, Jonathan |e verfasserin |4 aut | |
700 | 1 | |a Cherutich, Peter |e verfasserin |4 aut | |
700 | 1 | |a Kurth, Ann E |e verfasserin |4 aut | |
700 | 1 | |a Akiyama, Matthew J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Global public health |d 2006 |g 17(2022), 12 vom: 01. Dez., Seite 3627-3637 |w (DE-627)NLM185840353 |x 1744-1706 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2022 |g number:12 |g day:01 |g month:12 |g pages:3627-3637 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/17441692.2022.2110919 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2022 |e 12 |b 01 |c 12 |h 3627-3637 |